Evista

This page contains recent news articles, when available, and an overview of Evista but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Evista
(when available)

Pharmacology and use:
Raloxifene, a selective estrogen receptor modulator (SERM) of the benzothiophene class, is similar to tamoxifen in that it produces estrogen-like effects on bone and lipid metabolism, while antagonizing the effects of estrogen on mammary tissue. Raloxifene decreases bone resorption, increases bone mineral density (BMD) and decreases incidence of fractures. Raloxifene is used in the prevention of postmenopausal osteoporosis and breast cancer. For the prevention of osteoporosis in post-menopausal women

Mechanism Of Action:
Raloxifene binds to estrogen receptors, resulting in differential expression of multiple estrogen-regulated genes in different tissues. Raloxifene produces estrogen-like effects on bone, reducing resorption of bone and increasing bone mineral density in postmenopausal women. Raloxifene also antagonizes the effects of estrogen on mammary tissue and blocks uterotrophic responses to estrogen.

News Articles on Raloxifene

Treating breast cancer painful, scary  -  05 Jan 2010
I called Dr. Han at Moffitt, and she suggested I try a drug called raloxifene — brand name Evista. Raloxifene, an osteoporosis drug, reduces the occurrence ... The News-Press

Options for Bone Loss, but No Magic Pill  -  ‎Jan 4, 2010‎
Another effective antiresorptive drug is Evista (raloxifene), which has an added advantage of reducing the risk of breast cancer, but the disadvantage of ... New York Times

Lilly strong now, but future uncertain  -  ‎Dec 10, 2009‎
Between 2011 and 2014, drugs like Zyprexa, Cymbalta, Gemzar and Evista will all go off-patent. When Lilly released its annual report this morning, ... FiercePharma

Daiichi to use Ranbaxy network in Africa  -  ‎Dec 21, 2009‎
Before that, in September, Daiichi and Ranbaxy said that Terapia SA, a subsidiary of Ranbaxy in Romania, would market the osteoporosis medication, Evista in ... Financial Express

STOCKS NEWS US-Ciena loss widens. revenue tops expectations  -  ‎Dec 10, 2009‎
...when Lilly faces generic competition for schizophrenia drug Zyprexa, antidepressant Cymbalta, cancer drug Gemzar and osteoporosis treatment Evista. ... Interactive Investor

Ladies, Pick Your Cancer  -  ‎Dec 17, 2009‎
SERMs, like tamoxifen and Evista (raloxifene), could help mammogram readability and even prevent or treat breast cancer, except they increased the risk of ... The Epoch Times

Stocks, ETFs Move Higher as Trade Gap Narrows  -  ‎Dec 10, 2009‎
Wall Street is intently focused on the “patent cliff� when Lilly faces generic competition for their drugs – Zyprexa, Gemzar, Evista and Cymbalta. ... ETF Trends (blog)

2009 Biotech Cheers and Jeers  -  ‎Dec 22, 2009‎
...waiting to launch Prolia into a market that's produced plenty of blockbusters, including Eli Lilly's (NYSE: LLY) Evista and Merck's (NYSE: MRK) Fosamax. ... Motley Fool

LLY: Caris Cuts to “Holdâ€?  -  ‎Dec 11, 2009‎
Eli Lilly (LLY) is still trading down today, off 37 cents, or 1%, at $34.64, following an investor day presentation yesterday in which the ... Barron's (blog)

Cochabambinos califican de positiva gestión presidencial de Evo  -  ‎Dec 28, 2009‎
Los ciudadanos de diferentes condiciones sociales consideran como logros de la gestión "evista" las obras y proyectos del programa "Bolivia Cambia Evo ... Los Tiempos

Contradicciones en Copenhague  -  ‎Dec 25, 2009‎
Redoblo mi tambor en sentido de que así como entre lo “bolivariano� y lo “boliviano� median dos letras de diferencia, entre lo “chavista� y lo “evista� hay ... Los Tiempos

SERIES | 'Glee', cuatro nominaciones, y 'Family modern', una  -  ‎Dec 16, 2009‎
La evista 'The Hollywood Reporter' la situó entre las 10 mejores series de la década. Además, desde su estreno, ha estado siempre entre los cinco espacios ... elmundo.es

Eli Lilly ne donne pas prévisions pour la période 2011-2014  -  ‎Dec 10, 2009‎
...l'antidépresseur Cymbalta, le traitement du cancer Gemzar et le traitement contre l'ostéoporose Evista confrontés à la concurrence des génériques. ... Reuters

Las razones del éxito  -  ‎Dec 15, 2009‎
La pregunta tiene especial sentido para una oposición desorientada, que no logra ver en las fortalezas del proyecto evista las debilidades que allí se ... Los Tiempos

Más respeto que arrancó diciembre  -  ‎Dec 17, 2009‎
Ahora se presenta en la sala Mar del Plata y tiene por delante un gran desafío: amalgamar en su nueva obra, El pueblo quiere gozar - La r evista del ... Lanacion.com (Argentina)

"No aguanto el conchero"  -  ‎Dec 18, 2009‎
La creadora de las arrimas contó que durante el verano 2010 no hará temporada con teatro de evista y confesó que el conchero es malo para las mujeres. ... Pronto

ECONOMIC. Depozitul de medicamente prin care japonezii intră în Europa ...  -  ‎Dec 10, 2009‎
...„Terapia Ranbaxy este un jucător puternic în Europa, iar noi vom oferi o platformă unică pentru Daiichi Sankyo în procesul de lansare a Evista şi a multor ... Ziua de Cluj

Promising Drugs for Cervical Cancer  -  ‎Nov 9, 2009‎
So Chung and Lambert gave the mice either Faslodex, used to treat certain breast cancers, or Evista, used to treat osteoporosis and to reduce the risk of ... WebMD

Ongoing FDA issues aren't stopping Ranbaxy  -  ‎Nov 9, 2009‎
Together with Daiichi, Ranbaxy has been making progress in markets outside the US It's getting ready to launch Eli Lilly's osteoporosis drug Evista in ... FiercePharma

Drugs to deter cancer largely ignored, experts say  -  ‎Nov 12, 2009‎
In 1999, he had a chance to do another breast cancer prevention trial, this time of the drug raloxifene, or Evista. The $110 million study, involving 19000 ... Austin American-Statesman

Pfizer Broke the Law by Promoting Drugs for Unapproved Uses  -  ‎Nov 8, 2009‎
Twenty years later, in 2005, Lilly paid $36 million in a guilty plea to one federal misdemeanor for off-label marketing of Evista, a drug the FDA had ... Bloomberg

Lilly earnings boosted again by Cymbalta and Alimta  -  ‎Oct 22, 2009‎
The osteoporosis drug Evista (raloxifene), which is also approved for the prevention of breast cancer for certain postmenopausal women, had revenues of ... Pharma Times

Medicines to Deter Some Cancers Are Not Taken  -  ‎Nov 13, 2009‎
Then, in 1999, he had a chance to do another breast cancer prevention trial, this time of an osteoporosis drug, raloxifene, or Evista, which did not have ... StarNewsOnline.com

Osteoporosis update  -  ‎Oct 31, 2009‎
Another choice for therapy is Evista, which has a breast protective effect and reduces spine and non-vertebral fractures. Vertebral data are comparable but ... Glens Falls Post-Star

REG-Lilly (Eli) & Co: Lilly Rpts Solid 3Q09; Rev Full-Year 09 EPS Guidance  -  ‎Oct 21, 2009‎
The US District Court for the Southern District of Indiana upheld the company's method-of-use patents on Evista®. These patents provide protection for ... Reuters

Byetta gains approval as stand-alone diabetes drug  -  ‎Nov 2, 2009‎
Lilly's key products include antipsychotic Zyprexa, Cymbalta for depression and fibromyalgia, Gemzar and Alimta for cancer, Evista and Forteo for ... Indianapolis Star

Eli Lilly Units Pumping Up Drug Pipeline  -  ‎Nov 9, 2009‎
Other upcoming patent expiration dates on drugs like Cymbalta, Gemzar and Evista could further impact Lilly's top-line revenues. Since biotech drugs prove ... San Diego Business Journal

Eli Lilly and Company Q3 2009 Earnings Call Transcript  -  ‎Oct 21, 2009‎
On the legal front, the US District Court for the Southern District of Indiana upheld the company's method of use patents on Evista. ... Seeking Alpha (blog)

National osteoporosis day, a day of awareness  -  ‎Oct 20, 2009‎
These include Evista, Tamoxifen and various estrogen and testosterone hormone supplements. All of the above drugs serve in one way or another to block the ... Post Searchlight

Ranbaxy consolidated net profit at Rs 117 cr in Q3  -  ‎Oct 26, 2009‎
Extracting synergies from the hybrid business model of Ranbaxy and Daiichi Sankyo, the company launched Evista in Romania, an osteoporosis drug from Daiichi ... pharmabiz.com

Reportlinker Adds Regenerative Medicines: Bone and Joint Applications  -  ‎Nov 3, 2009‎
TO TREAT OSTEOPOROSIS 113 Hormones 114 Evista 114 Forteo 114 Forteo (Continued) 115 Forteo (Continued) 116 Miacalcin 117 STEROIDS AND OSTEOPOROSIS 117 ... IT News Online

As breast cancer treatments increase, so does hope  -  ‎Oct 21, 2009‎
For women after menopause, a drug called Raloxefine, which is marketed as Evista, also experienced the same amount of reduction in breast cancer recurrence. ... Carver Reporter

Fármacos para cancro da mama podem vir a combater cancro do colo do útero  -  ‎Nov 11, 2009‎
O medicamento fulvestrant (Faslodex®) contra o cancro da mama eo raloxifeno (Evista®) contra o cancro da mama ea osteoporose foram dados a ratos ... POP - Portal de Oncologia Portugês

유방암 치료제 2종, ìž?ê¶?경부암ì—?ë?„ 효과ì ?  -  ‎Nov 9, 2009‎
...ë‘? 약물ì?€ 세í?¬ì—?서 ì—?스트로ê²?ì?˜ 작용ì?„ 억제하는 약물로 풀베스트란트는 '파슬로ë?±ìФ(Faslodex)', ëž„ë¡?시펜ì?€ 'ì—?비스타(Evista)'로 íŒ?매ë?œë‹¤. ... 데일리팜

Félmilliárdból épült irodaház Szegeden  -  ‎Nov 12, 2009‎
...gyártással, forgalmazásával foglalkozik, a Zipper Kft. melynek profilja a gyógyszeripari kutatás, illetve az Evista Kft., mely arculattervezéssel, ... Népszava

Terapia trage in jos vanzarile Ranbaxy in Europa pana la -10%  -  ‎Oct 27, 2009‎
Anul acesta, producatorul clujean a inceput comercializarea Evista, primul medicament lansat in Europa dupa incheierea parteneriatului Ranbaxy-Daiichi ... Wall-Street

La peor campaña electoral de todas  -  ‎Oct 21, 2009‎
El entorno 'evista' trata de eliminar a sus adversarios desempolvando algunos procesos judiciales. Por si fuera poco, el masismo ha recurrido a la búsqueda ... El Deber

El fin de la polarización en Bolivia  -  ‎Nov 8, 2009‎
Justo en ese momento la polarización comenzó a ceder ya ser reemplaza por la hegemonía del polo evista. Los hitos del camino hacia la unipolaridad fueron ... Infolatam

Lo que no es, es  -  ‎Oct 29, 2009‎
Muere la Unión Juvenil Cruceñista y nace la Unión Juvenil Evista, dudo mucho que sea para persuadir y convencer, porque estos dos niveles sólo se alcanzan ... BolPress

æ—¥ 제네릭 시장 '외ìž?사 진출러시'  -  ‎Nov 2, 2009‎
...rabeprazole), 'ì—?비스타'(Evista, raloxifene), '미카르디스'(Micardis, telmisartan), 'ë ˆí?´ë?¼ìŠ¤íŠ¸'(Reclast, zoledronic acid)ì?˜ 만료가 예정ë?¼ 있다. ... 디지틀보사

ENTREVISTA A RONALD B. CÉSPEDES (Fundación Diversencia): “Aún es ...  -  ‎Oct 30, 2009‎
RBC: Siento que Evo Morales no tiene claramente una agenda a favor de las personas LGBT, pero me dirá algún evista (fanático seguidor de Evo Morales) que ... Dos Manzanas (blog)

כלל פיננסי×? על טבע: "×§×™×™×? '×?פסייד' מהשקות גנריות משמעותיות ומרכישה משמעותית ...  -  ‎Nov 4, 2009‎
...חשוב לשי×? לב, ×›×™ התפתחויות משפטיות של השקות משמעותיות כגון ×”- Evista (700M$) וה- Gezmar (1.7B$) וכן התבהרות מפת התחרות בהשקת ×”- Prevacid (3.4B$) הצפויה ... טלנירי

Evista Shines in Breast Cancer Trial  -  Apr 17, 2006
Eli Lilly (LLY Quote) will ask regulators to approve its osteoporosis drug Evista as a breast cancer preventer, thanks primarily to the positive findings of ... TheStreet.com - TheStreet.com (subscription)

FDA approves Lilly's Evista for breast cancer  -  Sep 14, 2007
By Val Brickates Kennedy, MarketWatch. BOSTON (MarketWatch) -- Eli Lilly & Co. said Friday that the Food and Drug Administration has approved its ... MarketWatch

Eli Lilly says FDA advisory committee recommends approval of Evista  -  Jul 24, 2007
LONDON (Thomson Financial) - Eli Lilly and Company said that the Oncologic Drugs Advisory Committee of the US Food and Drug Administration voted to ... Forbes

Evista Can Raise Stroke, Blood Clot Risk  -  Jul 13, 2006
By Salynn Boyles. Hopes that the osteoporosis drug Evista would offer women a clearly safer alternative to tamoxifen for breast cancer prevention have been ... FOXNews

FDA will weigh Evista's cancer-reducing benefits  -  Jul 22, 2007
Evista was approved to prevent osteoporosis in 1997 and to treat it in 1999. ... Women and doctors might be more open to Evista because it seems to be safer ... USA Today

Evista Illustrates Drug Risk and Reward  -  Jul 13, 2006
New research from Eli Lilly(LLY Quote) demonstrates the difficulty that doctors, patients and, yes, investors face in balancing the benefits and risks of a ... TheStreet.com - TheStreet.com (subscription)

Evista May Help Prevent Endometrial Cancer  -  May 16, 2005
By Charlene Laino. Women who took Evista "had about half the risk of endometrial cancer than those not using the drug," says researcher Angela DeMichele, ... FOXNews

Lilly's Evista Trial Data Won't Boost Sales  -  Apr 12, 2006
Prudential Equity Group maintained a "neutral weight" rating on Eli Lilly after the drug company released mixed clinical trial data for Evista, ... Forbes

Lilly to pay $36M fine for false claims.  -  Dec 22, 2005
Those terms include giving Evista sales and marketing employees two hours of ... The special oversight of Lilly's marketing of Evista will last five years. ... Free with registration - St. Louis Post-Dispatch - AccessMyLibrary.com

Eli Lilly submits New Drug Application for Evista to US FDA  -  Dec 7, 2006
INDIANAPOLIS (AFX) - Eli Lilly and Co said it submitted a New Drug Application to the US Food and Drug Administration for Evista for the reduction in risk ... Forbes

Bone drug prevents one type of breast cancer: study  -  Jun 11, 2008
The osteoporosis drug Evista can help prevent breast cancer -- but only the type fueled ... Evista, known generically as raloxifene, is already approved for ... Reuters India

FDA Mulls New Use for Lilly Drug  -  Jul 20, 2007
The Food and Drug Administration has raised several questions about Eli Lilly's (LLY) request to have the osteoporosis drug Evista approved to reduce the ... TheStreet.com - TheStreet.com (subscription)

Bone drug prevents one type of breast cancer: study  -  Jun 10, 2008
The osteoporosis drug Evista can help prevent breast cancer -- but only the type fueled ... Evista, known generically as raloxifene, is already approved for ... Reuters

Lilly's Evista Data Likely Positive, Market Limited  -  Mar 24, 2006
Prudential Equity Group maintained a "neutral weight" rating on Eli Lilly ahead of the release of clinical trial data for Evista, an osteoporosis drug which ... Forbes

Wyeth: Menopause drug reduces multiple symptoms  -  Sep 25, 2008
There was no increased incidence of breast cancer in women taking Aprela, compared to those getting placebo or Evista, but breast cancer can take a decade ... USA Today

Lilly Settles Marketing Suit  -  Dec 22, 2005
Eli Lilly & Company has agreed to plead guilty to a misdemeanor and pay $36 million to settle criminal and civil complaints over the marketing of its Evista ... New York Times

Is Evista A Wonder Drug for Women? -  -  Aug 29, 2006
The headlines were intriguing: a drug that protects your bones while fighting off breast cancer. Who wouldn't want that? “Everyone is asking about this,� ... $2.95 - Newsweek - NewsBank

Atlanta health, diet and fitness news | ajc.com  -  May 10, 2005
Women who take the "generic Evista" product may be at risk for developing ... The genuine Evista is an osteoporosis treatment and prevention medication for ... Atlanta Journal Constitution

FDA Approves New Uses For Evista - Drug Reduces Risk Of Invasive …  -  Sep 17, 2007
The US Food and Drug Administration approved Evista (raloxifene hydrochloride) for reducing the risk of invasive breast cancer in postmenopausal women with ... Medical News Today - Medical News Today (press release)

ASCO: Evista or Tamoxifen? The Trade-Offs in Preventing Breast Cancer  -  Jun 6, 2006
By Peggy Peck, MedPage Today Staff Writer. ATLANTA, June 6 — Evista (raloxifene) may be a better choice than tamoxifen for preventing breast cancer in a ... MedPage Today

Gene Logic To Seek New Uses For Drugs  -  Sep 28, 2005
The Eli Lilly and Co. drug Evista had been intended as birth control. Now it is used to prevent osteoporosis. "This is the beginning of an important new ... Washington Post

Eli Lilly buys osteoporosis drug patch for $35M  -  Jun 12, 2008
Eli Lilly said the product acquisition would complement its current osteoporosis drugs, Evista and Forteo. The company added that that it would take a 2 ... Boston Globe

EVISTA SALES COULD SOAR FOLLOWING CANCER STUDY  -  Apr 19, 2006
Author: AP. Eli Lilly and Co.'s osteoporosis medication Evista could get a significant boost if the Food and Drug Administration approves it for use as a ... $2.95 - Press of Atlantic City, The - NewsBank

Evista from Canadian Pharmacy  -  Jun 4, 2007
...to try and maximise the Evista effects. This development phase can take up to 6 years the new medicine preventing other companies from producing that ... Sokwanele

Pfizer's Experimental Drug Is Linked to Excess Deaths  -  Sep 4, 2008
...s Evista, the FDA said. The drug would also compete with Novartis AG's Reclast, Roche Holding AG's Boniva, Procter & Gamble Co.'s Actonel and Merck & Co. ... Bloomberg

Be cautious about medications offered for bone thinning  -  May 17, 2005
Should a woman at 50 start taking drugs like Fosamax, Actonel or Evista to guard ... Fosamax and Actonel can cause small ulcers in the esophagus; Evista can ... Boston Globe

Evista 90 Pills X 60 Mg  -  Aug 2, 2007
...as an advanced degree program. The following is a partial list of North American universities that offer a degree in pharmacology or in related Evista 90 ... Sokwanele

Lilly Loses Patent Case to Ariad  -  May 5, 2006
Evista, one of Lilly's biggest drugs, was approved by the Food and Drug Administration in 1997 and had United States sales last year of $652.9 million. ... New York Times

Osteoporosis drugs oversold - docs  -  Jan 21, 2008
Makers of drugs such as Evista and Fosamax, among others, heavily promote the ... Officials at Eli Lilly, which makes Evista, were unable to comment. ... New York Daily News

Cheap Evista Without Prescription  -  Jul 28, 2007
...slightly, this will slightly alter the medicine's properties. This Cheap Evista Without Prescription when a useful Cheap Evista Without Prescription has ... Sokwanele

Evista.(Treat and prevent osteoporosis)(Drug overview)  -  Dec 1, 2005
Evista is prescribed to treat and prevent osteoporosis, the brittle-bone disease that strikes some women after menopause. A variety of factors promote ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

What's best for the breast  -  Apr 27, 2006
The osteoporosis drug Evista works as well as tamoxifen in reducing the risk of breast ... Evista does not carry several of tamoxifen's most serious risks, ... Sydney Morning Herald

Wyeth Menopause Drug Lessens Hot Flashes 80 Percent  -  Oct 5, 2007
Evista and an older generic medicine, tamoxifen, are in the same family of ... Evista and tamoxifen have been shown in studies to strengthen bones and ... Bloomberg

… Limited (TEVA) Announces Tentative Approval of Generic Evista(R) …  -  Apr 18, 2008
New Drug Application (ANDA) to market its generic version of Lilly's osteoporosis treatment Evista® (Raloxifene Hydrochloride) Tablets, 60 mg. ... Lifescience-online

Ariad says court rules in its favor in patent suit  -  Jul 9, 2007
...the patent claims asserted in the lawsuit were valid and infringed with respect to Eli Lilly's osteoporosis drug, Evista, and septic shock drug, Xigris. ... Reuters

Eli Lily Fined $36 Million Over Evista Promotion  -  Apr 8, 2005
Eli Lilly and Company has agreed to plead guilty and pay $36 million in connection with its illegal promotion of its drug Evista. ... Consumer Affairs

Do I Need to Take Calcium Supplements with Evista?  -  Oct 20, 2008
A question from a reader: I take Evista (60 mg) once a day and an over-the-counter calcium supplement twice a day (600 mg each dose). ... About.com - Drugs

Lilly's Zyprexa Keeps Analysts Edgy  -  Apr 20, 2006
Sales of the osteoporosis drug Evista fell 3% to $241.6 million, while sales of the multiple-use cancer drug Gemzar rose 11% to $338.8 million. ... TheStreet.com - TheStreet.com (subscription)

Lilly Violated Evista Consent Decree: Poll  -  Jul 27, 2007
By Ed Silverman // July 27th, 2007 // 7:06 pm. Two days ago, we pointed out a Lilly press release about an FDA panel endorsing its Evista osteoporosis med ... Pharmalot

Can Evista Help Reduce Risk?  -  Jul 7, 2008
QUESTION: My oncologist recommended Evista for me to prevent recurrence of breast cancer. I am so afraid of the side effects, as I am already experiencing ... Breastcancer.org

Article: Osteoporosis drug can prevent breast cancer, study shows. - ...  -  Apr 17, 2006
Article: FDA Approves New Uses for Evista Drug Reduces Risk of ... ... Evista is only the second drug approved to reduce the risk of breast cancer. ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research

DR. PAUL DONOHUE GOOD HEALTH  -  Mar 9, 2005
Actonel, Fosamax and Evista play havoc with me. -- M.Z. ... Evista is an estrogenlike product without the estrogen risk for breast cancer. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

FDA Approves Eli Lilly's Osteoporosis Drug Evista To Prevent Breast …  -  Sep 19, 2007
Eli Lilly on Friday announced that it has received FDA approval for its bone-strengthening drug raloxifene, sold under the brand-name Evista, to reduce the ... Medical News Today - Medical News Today (press release)

Osteoporosis Health Center  -  Nov 21, 2008
Raloxifene (Evista), a selective estrogen receptor modulator (SERM), which is used only in women. Raloxifene slows bone thinning and causes some increase in ... WebMD

Bausch & Lomb Shares Fall Further  -  Apr 12, 2006
Eli Lilly (LLY) says a study indicates that Evista did not increase or decrease ... Preliminary data from the strudy show that Evista decreased the risk of ... BusinessWeek

… COMPANY - Lilly Resolves Investigation-Evista Marketing. - PR...  -  Dec 21, 2005
LILLY (ELI) & COMPANY - Lilly Resolves Investigation-Evista Marketing. from PR Newswire UK Disclose. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Evista effective? Weight gain normal?  -  Oct 13, 2008
Question from RMoore: My hormonal therapy drug is Evista because I can't, for medical reasons, take any other med. Do you think Evista is as effective as ... Breastcancer.org

Cooling off on Evista recommendation  -  Oct 14, 2007
By Dr. Peter Gott | Columnist. Q. In a recent column, you recommended switching from Fosamax to Evista for the treatment of osteoporosis because of the ... Chicago Daily Herald - Chicago Daily Herald

Stroke risk identified for breast cancer drug  -  May 25, 2006
Raloxifene, sold as Evista, is a close relative of the older breast cancer drug ... Under the name Evista, raloxifene is currently prescribed for the ... CBC.ca

… warns about counterfeit Mexican Lipitor, Viagra, Evista.(Rx)(Brief...  -  Jul 1, 2005
The Food and Drug Administration is warning physicians and consumers about the sale of counterfeit versions of Lipitor, Viagra, and a product promoted as ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Evista breast cancer drug may be approved by an FDA panel soon  -  Aug 1, 2007
Eli Lilly's Evista breast cancer drug has seen sharp criticism from womens' groups and more -- and has seen opposition from the FDA as well. ... TopCancerNews.com

Old drug, new claim: the women-in-towels Evista ad explained. |...  -  Jul 1, 2008
Old drug, new claim: the women-in-towels Evista ad explained. ... find HealthFacts articles. The women in Eli Lilly's new ad campaign are attractive, ... Pay-Per-View - HealthFacts - HighBeam Research

… , Information and Resources Updated Daily-Heart-Evista Doesn't...  -  Apr 12, 2006
The drug Evista does not help protect the heart, according to early results ... "Because Evista did not prevent coronary events, we want to reinforce for ... HealthCentral.com

Does Evista increase chance of blood clots  -  Jul 1, 2006
DEAR DR. GOTT: I am 61 and have osteoporosis. I was on Actonel for six months in 2004 but was taken off of it because of serious eye problems. ... Lundington Daily News - Google News Archive

CARBON MONOXIDE'S DANGERS  -  Feb 19, 2006
Dear Dr. [Paul Donohue, M.D.]: You stated that Evista offers protection against breast cancer. I read the following: "Eli Lilly has agreed to plead guilty ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

Evista marketing  -  Dec 20, 2005
Indianapolis - Lilly has pleaded guilty to a federal misdemeanor in its marketing of raloxifene (Evista) and has paid $36 million in settlement [ 1 ]. ... Medscape

Teva Announces Tentative Approval of Generic Evista(R) Tablets  -  Apr 17, 2008
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted tentative approval for the Company's ... Genetic Engineering News - Genetic Engineering News (press release)

Evista Online Without Prescription  -  Apr 12, 2007
...is a vital concern Evista Online Without Prescription medicine, but also has strong economical and political implications. To protect the consumer and ... Sokwanele

Discount Evista Overnight Delivery  -  Aug 17, 2007
...of chemicals requires intimate knowledge of cell Discount Evista Overnight Delivery and biochemistry increasing, the field of medication is a vital concern ... Sokwanele

Eli Lilly responds to results of STAR trial comparing Evista with...  -  Apr 24, 2006
US drug major Eli Lilly says that the results of the National Cancer Institutes STAR (Study of Tamoxifen and Raloxifene) trial represent an important ... $4.95 - Pharma Marketletter - ECNext

Low Endogenous Estradiol, Raloxifene (Evista), Linked to Decreased …  -  Feb 21, 2006
By Paula Moyer. KISSIMMEE, FL -- February 21, 2006 -- Postmenopausal women who have low estradiol levels are at decreased risk of stroke, as are women with ... DG News

Article: Breast Cancer Indication May Help Evista - AP Online |...  -  Apr 18, 2006
Breast Cancer Indication May Help Evista ... find AP Online articles. ASHLEY M. HEHER, AP Business Writer AP Online 04-18-2006 Dateline: INDIANAPOLIS Eli ... Pay-Per-View - AP Online - HighBeam Research

Buy Evista Online  -  Aug 18, 2007
...is a partial list of North American universities that offer a degree in Buy Evista Online or in related disciplines. * University Buy Evista Online British ... Sokwanele

Purchase Evista No Rx  -  Nov 4, 2007
...neuro- and psychopharmacology (effects of medication is a Purchase Evista No Rx concern to medicine, but also has strong economical and political ... Sokwanele

Preliminary Coronary And Breast Cancer Results From Raloxifene Use …  -  Apr 15, 2006
EVISTA is not approved by the Food and Drug Administration (FDA) in the US for ... EVISTA did not increase or decrease the combined endpoint of non-fatal ... Medical News Today - Medical News Today (press release)

Purchase Evista COD  -  May 11, 2007
...beneficial effects. This Purchase Evista COD phase can take Purchase Evista COD to 6 years the new medicine preventing other companies from producing that ... Sokwanele

Legal: The Lilly Red Book: Feds Take Control Of Evista  -  Jan 9, 2006
Within the next 90 days, executives on Eli Lilly's Evista brand will be required to read and sign an agreement with the US Department of Justice, ... Brandweek Magazine

… Advisory Committee Recommends Approval of EVISTA for the Reduction...  -  Jul 24, 2007
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women. from ... Pay-Per-View - PR Newswire - HighBeam Research

is evista dangerous to use  -  Oct 20, 2008
I have started taking Evista. I have been doing some reading that scares me about the dangers of Evista. What can you tell me? Hi Avis: I hope I can help. ... HealthCentral.com

Cardiomyopathy can cause sudden death .  -  Mar 27, 2005
Actonel, Fosamax and Evista play havoc with me. —. It's not a sign of bone cancer. ... Evista is an product without the estrogen risk for breast cancer. ... Free-Lance Star - Google News Archive

Eli Lilly €400m funding to create 200 new jobs  -  Dec 4, 2006
...for a number of the company's most important drugs, including Zyprexa for the treatment of schizophrenia and Evista for the prevention of osterporosis. ... RTE.ie

For those with the gene, some options; Lifestyle changes and drugs...  -  Oct 1, 2007
In fact, Evista was approved Sept. 14 to reduce the risk of breast cancer in ... A drug similar to tamoxifen, called raloxifene or Evista, may soon be ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

Hormone Replacement Therapy (HRT) Breast Cancer - WebMD  -  Sep 1, 2006
Raloxifene (Evista) is a widely used SERM that has been shown to increase bone growth and density. Unfortunately it does not relieve symptoms of menopause, ... WebMD

Evista works for her, but is costly  -  May 24, 2007
Last year, with the approval of my gynecologist, I stopped taking Fosamax when I began having difficulty swallowing. He prescribed Evista as a substitute. ... $2.95 - Sun Herald - NewsBank

Media hype the new findings for Evista as an anti-breast cancer drug.  -  May 1, 2006
Initial results from a government-sponsored study indicate that the osteoporosis drug raloxifene (brand name: Evista) may protect against breast cancer. ... Pay-Per-View - HealthFacts - Factiva, from Dow Jones

… : LILLY (ELI) & COMPANY - FDA Approves EVISTA to Reduce Risk of …  -  Sep 14, 2007
LILLY (ELI) & COMPANY - FDA Approves EVISTA to Reduce Risk of Breast Cancer. from PR Newswire UK Disclose. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

test proves useful for  -  Mar 11, 2007
Dear Dr. Gott: I read your column faithfully, and, when I read your answer on Evista, I knew you were wrong. I do agree on the risks of using Fosamax, ... Reading Eagle - Google News Archive

Eli Lilly submits Evista NDA to FDA.  -  Dec 18, 2006
Eli Lilly submits Evista NDA to FDA. USA-based drug major Eli Lilly & Co says that it has completed the submission of a New Drug Application to the Food and ... $9.94 - Pharma Marketletter - Alacra Store

FDA Approves New Use of Eli Lilly Drug; Marketing Planned  -  Sep 17, 2007
The US Food and Drug Administration has given Eli Lilly and Co. the green light to market a new use of its blockbuster osteoporosis drug Evista. ... Mediapost.com

SCOLR Pharma Reports Raloxifene Study Validates Benefits of CDT(R) …  -  Jul 11, 2005
Raloxifene hydrochloride is the active ingredient in Evista(R), Eli Lilly's immediate release tablets ... Evista uses a different solubilization technology. ... businesswire.com

A Ton Of Prevention  -  Jul 3, 2006
Both tamoxifen and Evista block estrogen, a hormone that can promote tumor ... Evista, also known by its generic name raloxifene, is an Eli Lilly & Co. ... BusinessWeek

… osteoporosis drug: In a large government study, Evista worked as...  -  Apr 18, 2006
Tamoxifen caused 36 uterine cancers, compared with 23 among Evista users. ... Evista and tamoxifen, a breast-cancer therapy that in 1998 became the first ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research

Don't wait to get answers on lung issue  -  Apr 7, 2008
You mentioned that Evista can cause premature heart disease in some women. I currently take Evista with 1200 milligrams of calcium. ... Chicago Daily Herald - Chicago Daily Herald

The FDA has officially approved Evista for use in breast cancer...  -  Sep 30, 2007
It's interesting when a drug is re-purposed into something aimed at fighting cancer, but that is what has happened to Evista, a prescription drug made by ... TopCancerNews.com

FDA Warns that Mexican Drugs May Be Counterfeit  -  May 13, 2005
Women who take the substandard generic Evista product that contains no active ... The "generic Evista" was analyzed by FDA in coordination with the National ... Consumer Affairs

Press Release: FDA Approves New Uses for Evista Drug Reduces Risk of …  -  Sep 14, 2007
FDA Approves New Uses for Evista Drug Reduces Risk of Invasive Breast Cancer in Postmenopausal Women. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research

Lilly's Evista cleared by FDA for reducing risk of breast cancer.  -  Sep 24, 2007
The US Food and Drug Administration has approved drug major Eli Lilly's Evista (raloxifene HCl) for reducing the risk of invasive breast cancer in ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Raloxifene (Evista) therapy for the heart--good news, bad news.(Brief...  -  Sep 1, 2006
Women in the US take raloxifene (sold as Evista by Eli Lilly) to treat and prevent osteoporosis. Because raloxifene is also known to lower cholesterol ... Free with registration - Healthy Years - AccessMyLibrary.com

… and Company Submits New Drug Application for EVISTA for Reduction...  -  Dec 7, 2006
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… : FDA approves new uses for Evista.(Industry News) - Pharmaceutical...  -  Oct 1, 2007
FDA approves new uses for Evista.(Industry News) ... find Pharmaceutical Processing articles. The FDA has approved Evista (raIoxifene hydrochloride) for ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research

ASK un. GOTT Osteoporosis drug Evista has some side effects .  -  Oct 28, 2007
Dear Dr. Gott: I am 54 ears old and six months into menopause. Although I take calcium supplements, my doctor wants me to take vista. ... Southeast Missourian - Google News Archive

Press Release: Lilly Statement on STAR. - PR Newswire | HighBeam …  -  Apr 17, 2006
Importantly, Evista is currently marketed in the U.S. for the prevention and ... Article: FDA Advisory Committee Recommends Approval of EVISTA for ... ... Pay-Per-View - PR Newswire - HighBeam Research

Evista aids bone health in lupus patients  -  Dec 29, 2005
NEW YORK (Reuters Health) - A small study has shown that the osteoporosis drug raloxifene, sold as Evista, helps maintain bone mineral density (BMD) in ... RedOrbit

Advisory panel sets meeting to consider Evista for breast cancer  -  Aug 1, 2008
An FDA advisory committee plans to meet Tuesday to weigh the efficacy of using the Evista osteoporosis drug for lowering the risk of breast cancer. ... SmartBrief

Insidermedicine in 60 - TB, Evista, Obesity & Education, HIV Drugs  -  Jul 25, 2007
Health authorities are warning that anyone traveling on a bus from Boston to Montreal on May 5th be tested for TB. This is because a man with active TB was ... Insidermedicine

Press Release: Lilly Announces Preliminary Coronary and Breast Cancer...  -  Apr 12, 2006
Raloxifene HCl is currently marketed in the U.S. as EVISTA(R) for the ... EVISTA is not approved by the Food and Drug Administration (FDA) in the U.S. for ... Pay-Per-View - PR Newswire - HighBeam Research

The Risks and Benefits of a New Drug for Osteoporosis  -  Sep 8, 2008
The benefits of lasofoxifene, a selective estrogen receptor modulator that is the second drug in its class (Eli Lillly's raloxifene or Evista, approved in ... GoozNew

No Treatment Helps Woman's Osteoporosis .  -  Oct 2, 2005
Subsequently, I have been tried on Evista, and, now, . each case, I experience leg pain in the calf, plus a burning sensation, causing the doctor concern of ... Reading Eagle - Google News Archive

… warns about counterfeit Mexican Lipitor, Viagra, Evista.(Rx)(Brief...  -  Jul 1, 2005
FDA warns about counterfeit Mexican Lipitor, Viagra, Evista.(Rx)(Brief Article) ... find Internal Medicine News articles. The Food and Drug Administration ... Pay-Per-View - Internal Medicine News - HighBeam Research

Author: Leading UK lender gets bailout  -  Sep 16, 2007
Eli Lilly and Co. can sell its osteoporosis drug Evista to doctors as a two-for-one ... The US Food and Drug Administration approved the use of Evista as a ... $2.95 - Republican-American - NewsBank

Brand Names/Synonyms:
Evista is also known by the following brand names and/or synonymsCCRIS 7129; CHEMBANK1694; Evista; Keoxifene; RAL; Raloxifene; Raloxifene Hcl; Raloxifene Hydrochloride; Raloxifeno [Spanish]; Raloxifenum [Latin]

Drug Category:
Evista is categorized under the following by the FDA: Antihypocalcemic Agents; Osteoporosis Prophylactic; Selective Estrogen Receptor Modulators; Estrogen Antagonists; ATC:G03XC01

Dosage Forms:
Tablet

Absorption:
Approximately 60% of an oral dose is absorbed, but presystemic glucuronide conjugation is extensive. Absolute bioavailability of raloxifene is 2.0%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
[6-hydroxy-2-(4-hydroxyphenyl)-benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]-methanone





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy